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Several major invasive bacterial pathogens are encapsulated. Expression of a polysaccharide capsule is essential for
survival in the blood, and thus for virulence, but also is a target for host antibodies and the basis for effective vaccines.
Encapsulated species typically exhibit antigenic variation and express one of a number of immunochemically distinct
capsular polysaccharides that define serotypes. We provide the sequences of the capsular biosynthetic genes of all 90
serotypes of Streptococcus pneumoniae and relate these to the known polysaccharide structures and patterns of
immunological reactivity of typing sera, thereby providing the most complete understanding of the genetics and
origins of bacterial polysaccharide diversity, laying the foundations for molecular serotyping. This is the first time, to
our knowledge, that a complete repertoire of capsular biosynthetic genes has been available, enabling a holistic
analysis of a bacterial polysaccharide biosynthesis system. Remarkably, the total size of alternative coding DNA at this
one locus exceeds 1.8 Mbp, almost equivalent to the entire S. pneumoniae chromosomal complement.
Citation: Bentley SD, Aanensen DM, Mavroidi A, Saunders D, Rabbinowitsch E, et al. (2006) Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal
serotypes. PLoS Genet 2(3): e31.
Introduction
Streptococcus pneumoniae (the pneumococcus) is a major
cause of morbidity and mortality worldwide, causing diseases
that range in severity from meningitis, septicaemia, and
pneumonia to sinusitis and acute otitis media [1,2]. Factor
(typing) sera are used to divide pneumococci into serotypes
and serogroups, which include immunologically related
serotypes. These sera have been developed by a process of
multiple cross-absorptions, which render them speciﬁc for
the immunochemical differences between the pneumococcal
capsular polysaccharides (CPSs) [3]. At present, 90 individual
serotypes are recognised by their patterns of reactivity with
the factor sera [4], and serotypes vary in the extent to which
they are carried in the nasopharynx and the degree to which
they are recovered from different disease states [5,6].
Expression of a capsule is important for survival in the blood
and is strongly associated with the ability of pneumococci to
cause invasive disease. The capsule is surface exposed, and
antibodies against CPS provide protection against pneumo-
coccal disease. Consequently, polyvalent polysaccharide
vaccines have been developed in which CPS from the
serotypes most commonly associated with invasive disease
in children are linked to a protein carrier, and a seven-valent
conjugated polysaccharide vaccine has been introduced and
shown to be highly effective [7,8]. A 23-valent polysaccharide
vaccine is also available for use in adults [9].
With the exception of types 3 and 37, which are synthesised
by the synthase pathway [10–14], pneumococcal CPSs are
generally synthesised by the Wzx/Wzy-dependent pathway
(Figure 1). The genes for the latter pathway are located at the
same chromosomal locus (cps), between dexB and aliA [15–17].
CPSs are synthesised by transfer of an initial monosaccharide
phosphate from a nucleotide diphosphate sugar to a
membrane-associated lipid carrier, followed by the sequential
transfer of further monosaccharides to produce the lipid-
linked repeat unit. This is transferred to the outer face of the
cytoplasmic membrane by the repeat-unit transporter or
ﬂippase, polymerised to form the mature CPS, and then
attached to the peptidoglycan [18]. The cps locus therefore
typically encodes the enzymes to build the repeat unit,
including an initial glycosyl phosphate transferase, and
additional transferases responsible for the formation of the
linkages, and to allow for the addition of sugars (or other
moieties), or to otherwise modify the repeat unit, as well as a
repeat-unit ﬂippase and polymerase [15].
The substantial diversity of pneumococcal CPSs is believed
to have arisen as a consequence of selection for antigenic
diversity imposed by the human immune system [6]. The
evolutionary timescales and the genetic events by which novel
serogroups and serotypes arise are unclear. Comparisons of
the available cps loci indicate a variety of genetic mechanisms
and show that the central genes responsible for the synthesis
and polymerisation of the repeat unit are highly variable and
often non-homologous between serotypes. These genes have a
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frequently have been generated by the introduction of novel
cps genes into pneumococci by lateral gene transfer from
other species. A much better understanding of the complex
mechanisms by which antigenic diversity arises could be
obtained by using the sequences of the complete set of
pneumococcal cps loci. We therefore obtained sequences of
the cps locus for all 90 serotypes and used these data, together
with the available polysaccharide structures and the patterns
of serological reactions with typing sera, to explore the
genetics of capsular diversity in this major pathogen. Here we
present highlights of our analysis to date, and a more
exhaustive analysis will be reported elsewhere.
Results
General Features of the dexB–aliA Locus from 90 Serotypes
PCR products were generated from genomic DNA using
primers speciﬁc for the dexB and aliA genes and ranged in size
from 10,337 bp (serotype 3) to 30,298 bp (serotype 38) with an
average of 20,714 bp. The synthase gene (wchE) of serotype 3 is
located within the cps locus, but the type 37 cps locus, which
was very similar to that of serotype 33F, is defective and
serotype is determined by the type 37 synthase gene (tts)
located elsewhere on the chromosome [10]. Annotation and
analysis of the cps sequences revealed the generality of several
previously observed characteristics. Genes for the generation
of CPSs are always orientated in the same direction as the
dexB and aliA genes (Figures 2 and S1). The regulatory and
processing genes wzg, wzh, wzd, and wze (also known as
cpsABCD) are conserved with high sequence identity in all
cases and are almost always in this gene order at the 59 end of
the cps locus. In most cps clusters, the ﬁfth gene encodes the
initial glucose phosphate transferase, WchA (also known as
CpsE), responsible for linkage of an activated glucose
phosphate to the lipid carrier (see below). The polysaccharide
polymerase (wzy) and ﬂippase (wzx) genes are always present
downstream together with a varying set of genes for glycosyl
transferases, acetyl transferases, nucleotide diphosphate
sugar biosynthesis, and modifying enzymes.
In every case, there is a region of low percentage GþC
content within the cps locus. The ﬁrst four genes and the non-
housekeeping sugar biosynthesis genes have typical percent-
age GþC content for S. pneumoniae, while the ‘‘serotype-
speciﬁc’’ genes, particularly wzy and wzx, tend to have more
AT-rich sequences. In the regions between the cps genes and
the ﬂanking dexB and aliA genes, there is almost always
evidence of mobile genetic elements. This is largely man-
ifested as intact or disrupted genes for insertion-sequence
(IS) transposases [19,20], although in four cases we identiﬁed
group-II introns [21] (serotypes 19F, 25F, 25A, and 38).
We could assign a functional designation to the products of
all but 26 of the 1,999 predicted coding sequences in the 90
cps regions, with most of the remainder showing weak
similarities to products of genes in bacterial polysaccharide
gene clusters. Unsurprisingly, many coding sequences fall
into the broad functional categories of glycosyl transferase
(351), acetyl transferase (74), and sugar phosphate transferase
(71). To make more speciﬁc assignments within such
categories, we used the TribeMCL program to assemble all
the annotated proteins into homology groups (HGs). With
from two to 90 members in each, 91% of the proteins
assembled into 175 HGs, with the remainder forming 74
single-member HGs (Table S1). The products of wzg, wzh, wzd,
and wze each fall into a single HG covering every serotype.
Ignoring IS element transposases, the next largest HG
comprises 65 WchA initial transferases (HG5). At the other
extreme, the serotype-speciﬁc gene products are diverse, with
87 HGs for non-initial sugar transferases and 40 and 13
groups of Wzy repeat-unit polymerases and Wzx ﬂippases,
respectively.
Biosynthesis of Precursors for Sugars and Other CPS
Components
Of the 18 sugars and related compounds found in S.
pneumoniae capsules, seven are available from housekeeping
metabolic pathways and nine from known dedicated pathways
encoded within the cps cluster (Figure S2). This includes 4-
keto-N-acetyl-D-quinovosamine (UDP-KDQNAc), which is the
intermediate in the two step reaction catalysed by FnlA [22].
Wefoundaperfectcorrelationbetween thepresenceofanon-
housekeeping sugar in the CPS and the presence of the
appropriate biosynthetic genes in the cps locus. Two of the
three remaining compounds are the sugar alcohol phosphates
arabinitol-1-P and mannitol-6-P. The precursors for these
have not been identiﬁed, but nucleotide-diphosphate-linked
precursors can be easily derived from D-xylulose-5-phosphate
or D-fructose-6-phosphate, respectively, by two-step pathways
parallel to that for CDP-ribitol formation from ribulose-5-
phosphate [23]. D-xylulose-5-phosphate and D-fructose-6-
phosphate are central to major pathways, and there are
appropriate genes for their conversion in the associated cps
loci. The precursor for ribofuranose has also not been
identiﬁed, but a proposed pathway for its biosynthesis by the
product of a gene within CPS 19F (cps19R) [24] is supported by
our observation that an orthologous gene (renamed rbsF)i s
present for all CPS that contain ribofuranose.
Choline-1-phosphate, glycerol-1-phosphate, and glycerol-2-
phosphate are also found in some of the structures. CDP-
choline is known to be produced by S. pneumoniae as a
precursor for teichoic acid biosynthesis [25]. For glycerol-1-
phosphate, we ﬁnd an intact gct gene for CDP-glycerol
synthesis [26] in the cps where expected, and there are four
genes associated with presence of glycerol-2-phosphate, three
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Synopsis
Several major bacterial pathogens are coated by a polysaccharide
capsule that is important for virulence. Each strain of Streptococcus
pneumoniae (the pneumococcus) produces one of 90 different
capsular polysaccharides, which are distinguished by using a set of
antisera that recognise the chemical differences in the capsules. The
capsule is important for virulence, but is immunogenic, and the
large number of different capsular serotypes is believed to have
been selected as a mechanism to evade the human immune
response. Antibodies against capsular polysaccharide can protect
against pneumococcal disease, and a highly effective protein-
conjugated polysaccharide vaccine that protects children against
the seven serotypes most commonly associated with serious disease
has recently been introduced in the United States. Bentley and
colleagues have determined the DNA sequence of the capsular
biosynthesis genes for all 90 serotypes of S. pneumoniae and, by
correlating the gene content with the serological profiles and with
the known capsular polysaccharide structures, provide what they
believe to be the most detailed and complete understanding of
capsular biosynthesis and capsular gene evolution in any bacterial
pathogen.Figure 1. Representation of the Wzx/Wzy-Dependent Pathway for Biosynthesis of CPS 9A
Pictured is a hypothetical model for capsule biosynthesis in S. pneumoniae based on a mixture of experimental evidence and speculation. For a recent
review, see Yother [15].
(1) Non-housekeeping nucleotide sugar biosynthesis.
(2) The initial transferase (WchA in this case) links the initial sugar as a sugar phosphate (Glc-P) to a membrane-associated lipid carrier (widely assumed
to be undecaprenyl phosphate).
(3) Glycosyl transferases sequentially link further sugars to generate repeat unit.
(4) Wzx flippase transports the repeat unit across the cytoplasmic membrane.
(5) Wzy polymerase links individual repeat units to form lipid-linked CPS.
(6) Wzd/Wze complex translocates mature CPS to the cell surface and may be responsible for the attachment to peptidoglycan. The complex of WchA,
Wzy, Wzx, Wzd, and Wze shown in the membrane is based on that in Figure 2 of Whitfield and Paiment [47] for the related Escherichia coli Type 1
capsule.
Found at DOI: 10.1371/journal.pgen.0020031.g001
Figure 2. Capsule Biosynthesis Genes and Repeat-Unit Polysaccharide Structures
Shown are the cps gene clusters for cases discussed in the text, together with the polysaccharide structure of the encoded repeat unit where known [31]
(the full set is shown in Figure S1). Genes are represented on the forward and reverse strands by boxes coloured according to the gene key, with gene
designations indicated above each box. Grey blocks indicate regions of sequence similarity between gene clusters. Repeat-unit structures are displayed
withthelinkagetoundecaprenylpyrophosphateattheright-handside(notnecessarilythecaseforthepublishedstructures[31]),soresiduenumbersare
counted from right to left. Monosaccharides are represented as shapes coloured according to the structure key. Housekeeping sugars are coloured grey.
Non-housekeeping sugar colours correspond to the associated sugar biosynthesis gene colours. Glycerol, choline, and acetate are indicated as text. Also
shown are the nature of linkages with the associated gene, and the linkages between repeat units created by the Wzy polymerase. Gene designations are
in parentheses where their substrate specificity is unclear.
Found at DOI: 10.1371/journal.pgen.0020031.g002
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[27], while wchX encodes the glycerol phosphotransferase.
The situation is illustrated in Figure 1 for cps9A, which has
pathway genes for N-acetylmannosamine pyranose and
glucuronic acid, but not for glucopyranose (Glcp)o r
galactopyranose (Galp) as these are available in S. pneumoniae
from central metabolism.
Initial Transferases and Polymerisation
Initial transferase WchA adds glucose-1-phosphate to
undecaprenol phosphate [28] to create Und-PP-Glc (Figure
1), and we assume it performs that function in all 65 serotypes
where it is present. For the known structures, there is a
perfect correlation between the presence/absence of wchA
and the presence/absence of glucose in the repeating unit.
Where wchA is absent, the products of the ﬁfth cps gene fall
into three HGs (WciI, WcjG, and WcjH) all with the same
Pfam [29] domain and similar hydrophobicity proﬁles to the
carboxy-terminal region of WchA. We suggest that they
function as the initial sugar transferases, as it is known that
for the Salmonella enterica wchA homologue, wbaP, the 39 end of
the gene is sufﬁcient for transferase activity [30]. By
correlation with CPS constituents, we predict the transferred
initial sugars as N-acetylgalactosamine pyranose (GalpNAc) or
N-acetylglucosamine pyranose (GlcpNAc) for WciI, Galp or
galactofuranose for WcjG and Galp for WcjH. Serotype 1 is an
exception as no gene product with similarity to an initial
sugar transferase has yet been identiﬁed.
The initial sugar of the repeat unit is also the donor sugar
in the polymerisation of the repeat units (Figure 1), and the
speciﬁcity of the Wzy polymerase determines the other
component of this linkage, which in the case of CPS 9A is a
beta (1–4) linkage to the terminal glucose of the next repeat
unit. For the known structures [31], identiﬁcation of the
initial sugar allowed us to determine the polymerase linkage
as both donor and acceptor sugar, and the linkages were
deﬁned once the initial sugar had been identiﬁed (see Figures
2 and S1). Where there is ambiguity due to two residues of the
initial sugar in the repeat unit, the polymerase linkage can be
provisionally identiﬁed by considering the linkage catalysed
by other members of the same Wzy HG. The predictions for
initial sugars, and subsequent repeat-unit polymerisation
linkage, correlate well with the polymerase HGs (Table S2).
There are 32 polymerase HGs associated with WchA, ﬁve with
WciI, four with WcjG and one with WcjH. These associations
are mostly exclusive, with only ﬁve polymerase HGs associ-
ated with two initial transferases. In such cases, the linkages
involve the same acceptor sugar anomerism (a or b isomer)
and the same or a closely related donor sugar. This adds
strong support to the inferences drawn for the speciﬁcity of
the initial transferases.
Relating cps Genes with CPS Structure and Serological
Profile
The availability of all of the annotated cps sequences allowed
us to look for correlations between genes, known CPS
structures, and serology (gene clusters, CPS structures, and
antigenicformulaearesummarisedinFigureS1andTableS3).
In this way, we can attempt both to infer gene function and, by
comparing related cps loci, to account for differences in CPS
structure and serology. Variations between cps loci range from
two base substitutions for 18B and 18C to wholesale differ-
ences in gene complement. Within this range, the variations
likely to have a phenotypic effect include gene inactivation
due to single base substitutions generating a premature stop
codon, single base insertion/deletions leading to translational
frameshifts, change of sequence leading to change of enzyme
speciﬁcity, recombination or IS element insertion leading to
gene truncation, and insertion/deletion/replacement of single
andmultiplegenes.Withinserogroups, thegenetic differences
were often subtle but were also sometimes surprisingly
prominent. Comparisons also revealed some strong common-
ality between the cps of different serogroups and serotypes.
Illustrative examples that demonstrate how structure, genet-
ics, and serology were combined to analyse the cps loci are
shown in Figure 2 and are discussed below.
Serogroup 9
Previously described CPS structures [31] for all four serotypes
of serogroup 9 show only subtle differences and provide an
example of multiple serotypes arising by divergence from a
single cps locus. Their cps genes fall into two pairs, with 9A highly
similar to 9V [32], and 9L highly similar to 9N, but with the two
pairs differing signiﬁcantly in sequence ( Figure 2), suggesting
an initial divergence to form two ancestral serotypes; this split
correlates with a difference at residue 5 of the repeat unit,
where 9L and 9N CPSs have GlcpNAc, whereas 9A and 9V have
Glcp. Factor sera 9d reacts with 9A and 9V but not with 9L and
9 N ,s u g g e s t i n gt h a ti ti si n t e r a c t i n gw i t hG l c p but not with
GlcpNAc. Both are housekeeping sugars, and their differential
incorporation is likely to be due to divergent forms of glycosyl
transferase WcjC. Subsequently, one of these ancestral serotypes
diverged to form 9L and 9N, the latter becoming unique in the
group in having Glcp rather than Galp as residue 3 in the repeat
unit. Their dexB–aliA loci have the same gene complement, and
within the cps genes there are only 79 nucleotide differences.
The highest number of amino acid substitutions (13) is within
glycosyl transferase WcjA; ten are unique to 9N and presumably
result in its altered speciﬁcity for Glcp rather than for Galp.
The other ancestral serotype gave rise to 9V and 9A, which
differ from each other only in their CPS acetylation; the
former CPS has an O-acetylation pattern unique in the
serogroup. This is likely due to the O-acetyl transferase–
encoding wcjE gene, which is intact and apparently functional
in 9V, disrupted by a frameshift mutation in 9A (deletion of
guanine, nucleotide 726), and truncated in 9L and 9N by the
insertion of an IS element. Interestingly, factor sera 9g reacts
only with serotype 9V and may recognise an acetyl-based
epitope determined by wcjE.
Serogroup 9 cps loci also differ by the insertion, in 9A and
9V relative to 9L and 9N, of an O-acetyl transferase gene
(wcjD) and an adjacent IS element. This correlates with recent
nuclear magnetic resonance data (I. C. Skovsted, unpublished
data), indicating that 9A CPS is partially acetylated.
Serotypes 44 and 46 Are Related to Serogroup 12
The cps gene clusters of serogroup 12 and serotypes 44 and
46 are almost identical, differing only in IS transposase genes,
and provide an example of common ancestry that is not
apparent from serology. Structures have been determined for
serotypes 12F and 12A only, although the individual
constituents for serotype-46 CPS are known and all are
present in 12F and 12A [31]. Although no factor serum cross-
reacts with all ﬁve serotypes, serological reactions do indicate
antigenic commonalities [4]; 44 cross-reacts with factor sera
12b and 12d, while 46 cross-reacts with 12c. Given the cps
similarities, the signiﬁcant differences between 12F and 12A
CPS are perhaps surprising; 12A has a GalpNAc and 12F has a
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in 12F and GlcpNAc in 12A. The nucleotide differences are
concentrated within two glycosyl transferase genes (wciI and
wcxB), and we predict that the initial transferases, WciI–12A
and WciI–12F, with 38 amino acid differences, link GlcpNAc
and GalpNAc, respectively, to the lipid carrier, while WcxB–
12A and WcxB–12F, with 17 amino acid differences, account
for the side-branch difference.
Serotype 14 Is Closely Related to Serogroup 15
Serotype 14 shares no signiﬁcant serological cross-reaction
with serogroup 15, or with any other serotype, but the cps loci
of these two serotypes are clearly related. All CPS structures
for serotype 14 and serogroup 15 are known [31,33,34], and
comparisons of structures and genes allow inferences about
one to be made from the other. The four serogroup 15
pentasaccharide repeat units are identical, but polymer-
isation forms a linear polymer in 15A and 15F and a branched
structure in 15B and 15C that correlates with the presence of
wzy genes of different HGs (see Table S2). Serotypes 15B and
15C differ in the presence or absence of O-acetylation [35]
and, as previously described [36], the difference is due to a
variable-length TA tandem repeat region at the 59 end of
wciZ—in frame in 15B and out of frame in 15C strains. This
gene is in frame in 15F (acetylated), but extensively degraded,
rather than simply out of frame, in 15A (not acetylated).
Genes for synthesis of glycerol-2-phosphate (gtp1, gtp2, and
gtp3) are present in all serogroup 15 cps loci, but glycerol was
reported to be present only in 15A, being replaced by
choline-P in 15F, 15B, and 15C, with either residue being
present on only a proportion of the repeat units [31]. In all
cases, the transferase is presumed to be encoded by wchX,
with the molecular basis of the structural polymorphism
being contentious. However, recent nuclear magnetic reso-
nance analysis indicates that 15B contains glycerol and not
choline, suggesting that the same may also be true for 15F and
15C [34]. The 39 end of 15F cps has four extra genes—rmlB,
rmlD, glf, and a putative acetyl transferase gene wcjE—but they
appear to have no effect on the structure as there is no
rhamnose, galactofuranose, or extra acetylation in 15F CPS.
Indeed, rmlA and rmlC would also be required for rhamnose
biosynthesis. These four genes show synteny with the 39 end
of cps in several serotypes, particularly serotype 31, and their
arrangement in 15F may indicate a recombination event.
The serotype 14 [28,37,38] and basic 15 cps gene clusters
clearly share common ancestry and differ only at the 39 end,
where the glycerol-2-phosphate–related genes in 15 are
replaced in 14 by a gene (lrp) encoding a large (1,359 amino
acid) repetitive protein, which correlates well with CPS
structures [36]. The type-14 repeat unit most resembles the
branched form of 15B and 15C, with the lack of O-acetylation
due to the absence of wciZ. The lack of a-D-galactose is
probably due to degradation of the relevant transferase gene,
wchN. The large repetitive protein encoded by serotype-14 cps
has a hydrophobic C-terminal region, suggesting that it may
be anchored to the cell surface. This leads us to speculate that
Lrp may serve as a dominant antigen that overwhelms the
serological similarities to serogroup 15 that should be evident
from their very similar repeat units.
Discussion
Several bacterial pathogens exist as a large number of
antigenic variants because of differences in the polysaccha-
rides presented at the cell surface. However, the sequencing
and analysis of the cps loci of pneumococci described here are
believed to provide the only such case where the whole gene
repertoire is available, allowing genetics, chemistry, and
immunology to be combined to predict the role of cps genes.
This combined approach has allowed the conﬁdent predic-
tion of most gene functions, but it has also highlighted the
limitations where subtle sequence changes may alter enzyme
substrate speciﬁcity. Analysis of the cps loci indicates that a
number of different mechanisms have generated antigenic
diversity in CPSs. Some of these involve the divergence of a
single serotype into two related serotypes by the accumu-
lation of point mutations (e.g., serogroup 6 [39]), or the
insertion or deletion of a single gene, resulting in slightly
different CPS structures (e.g., serogroup 18). In other cases,
the cps loci of some serotypes within a serogroup seem to be
virtually unrelated and probably reﬂect the sharing of a
dominant epitope that led to them being placed within the
same serogroup (e.g., serogroups 7, 17, 33, and 35). Similarly,
some serotypes placed in different serogroups show more
relatedness among their cps loci than those within the same
serogroup (e.g., types 7B and 7C are more closely related to
type 40 than to 7A and 7F). This is perhaps not surprising as
serogroups were deﬁned by common epitopes in the absence
of any knowledge of the CPS structures or the cps sequences
that code for their synthesis. Shared immunodominant
epitopes will lead to inclusion in the same serogroup even
if there are major differences in other parts of the structure
and hence in the cps.
A striking feature of the cps loci is the presence of many
highly divergent forms of each of the key enzyme classes.
Thus, there are 40 HGs for polysaccharide polymerases, 13
groups of ﬂippases, and a great diversity of transferases. The
presence of multiple non-homologous or highly divergent
forms of these enzymes, together with the low percentage
GþC content of the region in which these are encoded,
supports the view that these genes have been imported into
pneumococci (or their ancestors) on multiple occasions from
different and unknown sources. The plethora of transferases
in the pneumococcal cps loci provides an opportunity to
continually generate new serotypes by gene shufﬂing, but
there are no clear examples of serotypes arising as mosaics of
two existing cps loci. One barrier to the frequent appearance
of new serotypes by recombination is a lack of homology
between the serotype-speciﬁc regions of cps loci of different
serogroups. The appearance of new serotypes may also be
limited by a need to change multiple cps genes; rare genetic
events that create mosaics between existing cps loci probably
typically fail to produce a capsule since new repeat units
resulting from the capture of novel transferases are unlikely
to be recognised as substrates by the resident repeat-unit
polymerase. The cps sequences, and their associated poly-
saccharide structures and serological proﬁles, constitute an
extensive dataset that, through further detailed analysis, will
allow a clearer understanding of capsule biochemistry,
genetics, and evolution and will precipitate advances in
molecular serotyping of pneumococci [40,41].
Materials and Methods
Strain selection, serotyping, and genomic DNA isolation. Repre-
sentative strains of the 90 S. pneumoniae serotypes were selected from
among the lyophilised strains in the strain collection of the World
Health Organization Collaborating Centre for Reference and
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Denmark) (Table S4). The strains were serotyped and cultured, and
genomic DNA was extracted by standard methods [3,4,42].
PCR and DNA sequencing. PCR reactions were performed using
the Expand Long Template PCR System (Roche, Basel, Switzerland),
which contains proof-reading thermostable polymerases. Initial
reactions used primers CPS1 (TTGCCAATGAAGAGCAAGACTTGA
CAGTAG) and CPS2 (CAATAATGTCACGCCCGCAAGGGCAAGT)
[26]. Where these failed to produce an adequate product, further
reactions were attempted using alternative dexB-speciﬁc primers
(CPS1A [CGACCGTCGCTTCCTAGTTGTGGCTAAC] or PCPS3f
[CACACAGAAAGCATCCCATGG]) and aliA-speciﬁc primers (CPS1B
[GTCTTGAGCTTTGACTGCCGCGTATTCT] or PCPS3r [GAGACA
GACCTGATAACCTCAACTATTTG]). The cps cluster for our sero-
type-5 strain was ampliﬁed using a primer based on the EMBL ﬁle
(AY336008) speciﬁc for the wzg gene (CPS05F [CGTTCACAGAAAGT
GAAGCG]) in combination with PCPS3r. PCR products spanning the
cps locus were used directly to construct small-insert libraries [43],
with 1- to 2-kb inserts in pUC18. Clones from each library were
sequenced from each end using Big-Dye terminator chemistry
(Applied Biosystems, Foster City, California, United States) on
ABI3730 sequencing machines, to give an average of 8- to 10-fold
coverage of each product. These reads were assembled with Phrap
(CodonCode, Dedham, Massachusetts, United States), and any gaps or
regions of poor coverage were re-sequenced using primer-directed
sequencing directly from the original PCR product using Big-Dye
primer chemistry (Applied Biosystems). This sequencing procedure
should prevent any PCR errors from being represented in the ﬁnal
consensus sequence.
Annotation and bioinformatic methods. Gene prediction and
annotation were performed as previously described [44]. Predicted
proteins were clustered into homology groups using TribeMCL
(Centre for Mathematics and Computer Science and EMBL-EBI) [45]
with a cut-off of 1e
 50. The genes within the cps loci that encoded
proteins within the same homology group were assigned the same
name, the exceptions being the polymerases and ﬂippases where we
used the prior gene nomenclature, wzy and wzx, even though in both
casesthereweremultiplehomologygroups.Alignmentofgeneclusters
was performed using the Artemis Comparison Tool (Sanger Institute,
Hinxton, United Kingdom). Nucleotide differences were identiﬁed
using the EMBOSS program Diffseq (MRC Rosalind Franklin Centre
for Genomics Research, Hinxton, United Kingdom) [46].
Supporting Information
Figure S1. Capsule Biosynthesis Genes and Repeat-Unit Polysaccha-
ride Structure for All 90 Serotypes
Found at DOI: 10.1371/journal.pgen.0020031.sg001 (9.9 MB TIF).
Figure S2. Biosynthesis Pathways for Non-Housekeeping Sugars
Found at DOI: 10.1371/journal.pgen.0020031.sg002 (50 KB PPT).
Table S1. Homology Groups including Numbers of Members and
Product Description
Proteins in different homology groups are so divergent that they are
highly unlikely to have diverged from a common streptococcal
ancestor.
Found at DOI: 10.1371/journal.pgen.0020031.st001 (306 KB DOC).
Table S2. Associations between Initial Transferases and Wzy
Polymerase Groups
Proposed Wzy groupings represent a sequential numbering of
homology groups and are represented on structural diagrams.
Found at DOI: 10.1371/journal.pgen.0020031.st002 (104 KB DOC).
Table S3. Type Designations and Antigenic Formulae for the 90
Serotypes of S. pneumoniae
The antigenic formulae represent arbitrary designations of cross-
reactions as seen by the capsular reaction.
Found at DOI: 10.1371/journal.pgen.0020031.st003 (72 KB DOC).
Table S4. Type and Strain Designations for the 90 Strains of S.
pneumoniae Analysed
Found at DOI: 10.1371/journal.pgen.0020031.st004 (68 KB DOC).
Accession Numbers
The EMBL Nucleotide Sequence Database (http://www.ebi.ac.uk/
embl), GenBank (http://www.ncbi.nlm.nih.gov/Genbank), and DNA
Data Bank of Japan (http://www.ddbj.nig.ac.jp/Welcome-e-html) ac-
cession numbers for the sequences reported in this paper for the
capsular biosynthetic genes of the 90 serotypes of S. pneumoniae are
CR931632–CR931722. The EMBL Nucleotide Sequence Database
(http://www.ebi.ac.uk/embl) accession number for the wzg gene is
AY336008. The Pfam domain (http://www.sanger.ac.uk/cgi-bin/Pfam)
for WchA, WciI, WcjG, and WcjH is PF02397.
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